News | December 17, 2024
Merck to acquire HUB Organoids to advance cell culture portfolio
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Modernization and supply chain diversity drive new growth
Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
Aims to achieve CDMO sales of US$ 400 million by 2028
_256_384.jpg)
Glenmark released Picture Post Cards on World Vitiligo Day
New leadership team announced at NATHEALTH Annual General Meeting 2024
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
An accomplished R&D leader and champion of the application of AI to drug discovery
Marks remarkable acceleration in innovation using AI technology
Subscribe To Our Newsletter & Stay Updated
